• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Tuesday

    3/22/22 12:33:10 PM ET
    $ACLX
    $AGTC
    $ALPP
    $BBN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $ACLX alert in real time by email

     

     

    Tuesday's session saw 52 companies set new 52-week lows.

    Interesting Points From Today's 52-Week Lows:

    • The largest company by market cap to hit a new 52-week low was Xometry (NASDAQ:XMTR).
    • Statera BioPharma (NASDAQ:STAB) was the smallest firm on a market cap basis to set a new 52-week low.
    • Statera BioPharma (NASDAQ:STAB)'s stock dropped the most, trading down 42.96% to reach a new 52-week low.
    • Werewolf Therapeutics (NASDAQ:HOWL)'s stock showed potential to rebound, rebounding up 0.0% after reaching a new 52-week low.

    During Tuesday, the following stocks broke to new 52-week lows:

    • Xometry (NASDAQ:XMTR) stock broke to a new 52-week low of $33.34 on Tuesday. Shares of the company traded up 0.03%.
    • BlackRock Taxable (NYSE:BBN) shares fell to $20.76 on Tuesday, setting a new 52-week low with a shift of down 1.18%.
    • Eaton Vance Municipal (AMEX:EIM) shares fell to $11.38 on Tuesday, setting a new 52-week low with a shift of down 0.31%.
    • Nuveen Dynamic Municipal (NYSE:NDMO) stock achieved a new 52-week low on Tuesday morning, hitting $13.10 and moving down 0.38%.
    • Blackrock Muniholdings (NYSE:MHD) shares hit a yearly low of $14.00. The stock was down 0.29% on the session.
    • Northfield Bancorp (NASDAQ:NFBK) shares moved up 0.47% on Tuesday to hit a new 52-week low of $14.77, drifting up 0.47%.
    • PIMCO Municipal Income (NYSE:PML) shares moved down 0.56% on Tuesday to hit a new 52-week low of $11.51, drifting down 0.56%.
    • Nuveen Intermediate Dur (NYSE:NID) shares hit a yearly low of $13.62. The stock was down 0.36% on the session.
    • Nuveen California (NYSE:NKX) stock broke to a new 52-week low of $13.41 on Tuesday. Shares of the company traded down 0.15%.
    • Invesco Trust (NYSE:VGM) shares moved down 0.26% on Tuesday to hit a new 52-week low of $11.42, drifting down 0.26%.
    • Blackrock Municipal IT (NYSE:BLE) stock broke to a new 52-week low of $12.27 on Tuesday. Shares of the company traded down 0.34%.
    • Cepton (NASDAQ:CPTN) stock dropped to a yearly low on Tuesday of $3.62. Shares traded down 1.33%.
    • Arcellx (NASDAQ:ACLX) shares set a new 52-week low of $14.18. The stock traded up 3.78%.
    • Cass Information Sys (NASDAQ:CASS) stock hit $37.44 on Tuesday morning, setting a new 52-week low for a change of down 1.24%.
    • BLACKROCK MUNIHOLDINGS (NYSE:MHN) shares were down 1.25% for the day, having made a 52-week low of $12.54.
    • Blackrock CA Muni Income (NYSE:BFZ) shares set a new 52-week low of $12.30. The stock traded down 0.28%.
    • Graphite Bio (NASDAQ:GRPH) stock set a new 52-week low of $5.54 on Tuesday, moving down 11.61%.
    • RiverNorth Managed (NYSE:RMM) shares set a new 52-week low of $16.93. The stock traded down 0.24%.
    • Blackrock Muniyield NJ (NYSE:MYJ) shares were down 0.02% for the day, having made a 52-week low of $13.59.
    • BLACKROCK MUNIYIELD (NYSE:MQT) shares set a new 52-week low of $12.05. The stock traded down 0.7%.
    • BlackRock MuniHoldings (NYSE:MUE) stock dropped to a yearly low on Tuesday of $11.70. Shares traded down 0.39%.
    • Powell Industries (NASDAQ:POWL) shares set a new yearly low of $20.18 this morning. The stock was down 1.82% on the session.
    • Pioneer Muni High Inc (NYSE:MAV) stock dropped to a yearly low on Tuesday of $9.84. Shares traded down 0.1%.
    • Invesco Trust For Invnt (NYSE:VTN) shares were up 0.68% for the day, having made a 52-week low of $11.65.
    • Alpine 4 Holdings (NASDAQ:ALPP) shares fell to $1.07 on Tuesday, setting a new 52-week low with a shift of down 5.13%.
    • Invesco Bond (NYSE:VBF) stock hit a yearly low of $17.08. The stock was down 0.27% for the day.
    • ORIC Pharmaceuticals (NASDAQ:ORIC) stock hit a yearly low of $3.94. The stock was down 32.11% for the day.
    • Nuveen Inter Dur Quality (NYSE:NIQ) stock dropped to a yearly low on Tuesday of $13.57. Shares traded down 0.66%.
    • Blackrock Muniyield (NYSE:MPA) shares reached a new 52-week low of $13.05 on Tuesday morning, moving down 0.91%.
    • Federated Hermes Premier (NYSE:FMN) shares set a new 52-week low of $12.74. The stock traded down 0.47%.
    • Quantum (NASDAQ:QMCO) shares set a new 52-week low of $2.29. The stock traded down 1.29%.
    • Western Asset Municipal (NYSE:MNP) shares moved down 0.44% on Tuesday to hit a new 52-week low of $13.52, drifting down 0.44%.
    • MFS Government Markets (NYSE:MGF) stock hit a yearly low of $3.75. The stock was down 0.27% for the day.
    • Nuveen Georgia Quality (NYSE:NKG) stock achieved a new 52-week low on Tuesday morning, hitting $11.50 and moving down 0.96%.
    • Werewolf Therapeutics (NASDAQ:HOWL) shares reached a new 52-week low of $4.17 on Tuesday morning, moving 0.0% (flat).
    • DWS Strategic Municipal (NYSE:KSM) shares set a new 52-week low of $10.33. The stock traded down 0.77%.
    • Nuveen Massachusetts (NYSE:NMT) shares hit a yearly low of $12.34. The stock was down 0.84% on the session.
    • RiverNorth Flexible (NYSE:RFM) stock hit $18.62 on Tuesday morning, setting a new 52-week low for a change of down 0.53%.
    • Mfs Inv Grade Municipal (NYSE:CXH) stock set a new 52-week low of $8.49 on Tuesday, moving up 0.06%.
    • Applied Genetic (NASDAQ:AGTC) stock hit a yearly low of $1.25. The stock was down 28.33% for the day.
    • Heritage Global (NASDAQ:HGBL) shares set a new yearly low of $1.28 this morning. The stock was down 3.73% on the session.
    • PIMCO New York Municipal (NYSE:PYN) shares made a new 52-week low of $8.04 on Tuesday. The stock was down 1.4% for the day.
    • Blackrock Enhanced Gov (NYSE:EGF) shares reached a new 52-week low of $11.15 on Tuesday morning, moving down 0.49%.

    Be sure to monitor Benzinga for the news traders need! And for even more up-to-date info on 52-week lows and highs, check out Benzinga Pro. This cutting-edge market research platform alerts traders of which stocks are trading near their 52-week highs and lows each morning - and delivers lots of other actionable data. Learn more here.

    Get the next $ACLX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACLX
    $AGTC
    $ALPP
    $BBN

    CompanyDatePrice TargetRatingAnalyst
    Powell Industries Inc.
    $POWL
    1/23/2026$427.00Neutral
    Cantor Fitzgerald
    Arcellx Inc.
    $ACLX
    1/7/2026$100.00Buy
    UBS
    Oric Pharmaceuticals Inc.
    $ORIC
    1/7/2026$22.00Overweight
    Piper Sandler
    Arcellx Inc.
    $ACLX
    12/22/2025$100.00Overweight
    Wells Fargo
    Werewolf Therapeutics Inc.
    $HOWL
    12/19/2025$1.00Outperform → Neutral
    Wedbush
    Oric Pharmaceuticals Inc.
    $ORIC
    11/20/2025$25.00Outperform
    Evercore ISI
    Oric Pharmaceuticals Inc.
    $ORIC
    11/18/2025Peer Perform
    Wolfe Research
    Arcellx Inc.
    $ACLX
    11/18/2025Peer Perform
    Wolfe Research
    More analyst ratings

    $ACLX
    $AGTC
    $ALPP
    $BBN
    SEC Filings

    View All

    SEC Form 8-K filed by Werewolf Therapeutics Inc.

    8-K - Werewolf Therapeutics, Inc. (0001785530) (Filer)

    2/6/26 4:41:00 PM ET
    $HOWL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Northfield Bancorp Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - Northfield Bancorp, Inc. (0001493225) (Filer)

    2/6/26 10:36:55 AM ET
    $NFBK
    Savings Institutions
    Finance

    SEC Form SCHEDULE 13G filed by Xometry Inc.

    SCHEDULE 13G - Xometry, Inc. (0001657573) (Subject)

    2/5/26 1:43:39 PM ET
    $XMTR
    Real Estate

    $ACLX
    $AGTC
    $ALPP
    $BBN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Bulldog Investors, Llp bought $80,648 worth of shares (10,119 units at $7.97) and sold $39,850 worth of shares (5,000 units at $7.97), increasing direct ownership by 68% to 12,907 units (SEC Form 4)

    4 - MFS INVESTMENT GRADE MUNICIPAL TRUST (0000847411) (Issuer)

    1/26/26 5:20:45 PM ET
    $CXH
    Investment Managers
    Finance

    Director Rappaport Alan bought $21,580 worth of shares (2,819 units at $7.66), increasing direct ownership by 54% to 8,001 units (SEC Form 4)

    4 - PIMCO MUNICIPAL INCOME FUND II (0001170299) (Issuer)

    12/10/25 6:50:44 PM ET
    $PML
    Investment Managers
    Finance

    Affiliate of the Adviser Rivernorth Financial Holdings, Llc bought $2,462 worth of shares (175 units at $14.07), increasing direct ownership by 0.43% to 40,647 units (SEC Form 4)

    4 - RiverNorth Flexible Municipal Income Fund, Inc. (0001790177) (Issuer)

    11/28/25 12:40:47 PM ET
    $RFM
    Finance/Investors Services
    Finance

    $ACLX
    $AGTC
    $ALPP
    $BBN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cantor Fitzgerald initiated coverage on Powell Inds with a new price target

    Cantor Fitzgerald initiated coverage of Powell Inds with a rating of Neutral and set a new price target of $427.00

    1/23/26 8:20:35 AM ET
    $POWL
    Electrical Products
    Energy

    UBS resumed coverage on Arcellx with a new price target

    UBS resumed coverage of Arcellx with a rating of Buy and set a new price target of $100.00

    1/7/26 9:34:38 AM ET
    $ACLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Piper Sandler initiated coverage on ORIC Pharmaceuticals with a new price target

    Piper Sandler initiated coverage of ORIC Pharmaceuticals with a rating of Overweight and set a new price target of $22.00

    1/7/26 9:13:12 AM ET
    $ORIC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACLX
    $AGTC
    $ALPP
    $BBN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: SEC Form 4 filed by Director Stahlin Paul

    4/A - Northfield Bancorp, Inc. (0001493225) (Issuer)

    2/6/26 6:13:31 PM ET
    $NFBK
    Savings Institutions
    Finance

    Amendment: SEC Form 4 filed by Director Catino Annette

    4/A - Northfield Bancorp, Inc. (0001493225) (Issuer)

    2/6/26 6:13:25 PM ET
    $NFBK
    Savings Institutions
    Finance

    Amendment: SEC Form 4 filed by Director Patafio Frank P.

    4/A - Northfield Bancorp, Inc. (0001493225) (Issuer)

    2/6/26 6:13:12 PM ET
    $NFBK
    Savings Institutions
    Finance

    $ACLX
    $AGTC
    $ALPP
    $BBN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

    SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Feb. 06, 2026 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that on February 2, 2026 (the "Grant Date"), ORIC granted a total of 173,800 non-qualified stock options and 28,700 restricted stock units to three new non-executive employees who began their employment with ORIC in January 2026. These inducement grants were granted pursuant to the ORIC Pharmaceuticals, Inc. 2022 Inducement Equity Incentive Plan, subject to recipient's continued employment or service through each applicable vesting date. Th

    2/6/26 4:30:00 PM ET
    $ORIC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences

    SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Feb. 05, 2026 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, announced that management will be participating in the following investor conferences in February: Guggenheim Emerging Outlook: Biotech Summit – Participating in a fireside chat on Thursday, February 12, 2026, at 10:30 a.m. ET. Management will also be participating in one-on-one meetings.Citi's 2026 Virtual Oncology Leadership Summit – Participating in a fireside chat on Wednesday, February 18, 2026, at 2:30 p.m. ET. Management will also be participating

    2/5/26 4:01:00 PM ET
    $ORIC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Arcellx Announces Late-Breaking Presentation at TANDEM Demonstrating Unique, High Target-Specificity of anito-cel's D-Domain Binder

    -- CAR constructs representative of anito-cel (D-Domain), cilta-cel (dual VHH), and ide-cel (scFv) were assessed preclinically for tonic signaling and off-target Claudin binding -- -- No tonic signaling or off-target activity was observed with the D-Domain, supporting its unique target-specific binding profile and anito-cel's potentially best-in-class safety profile -- -- Specific off-target activity against Claudin-9 was observed with the dual VHH binder, consistent with cilta-cel's publicly available regulatory assessment reports; the D-Domain and scFv binders did not demonstrate off-target activity -- -- CAR T activation and cytokine release were observed for dual VHH and scFv bind

    2/4/26 9:00:00 AM ET
    $ACLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ACLX
    $AGTC
    $ALPP
    $BBN
    Financials

    Live finance-specific insights

    View All

    Powell Industries Announces First Quarter Fiscal 2026 Results

    HOUSTON, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Powell Industries, Inc. (NASDAQ:POWL), a leading supplier of custom-engineered solutions for the management, control and distribution of electrical energy, today announced results for the first quarter Fiscal 2026 ended December 31, 2025. All comparisons are to the first quarter Fiscal 2025, unless otherwise noted. First Quarter Key Highlights:  Revenues of $251 million increased 4%;Gross profit of $71 million, or 28.4% of revenue, increased 20%;Net income of $41 million, or $3.40 per diluted share, increased 19%;New orders(1) totaled $439 million, an increase of 63%;Backlog(2) as of December 31, 2025 totaled $1.6 billion, an increase of 16%;Cas

    2/3/26 4:15:00 PM ET
    $POWL
    Electrical Products
    Energy

    Powell Industries Declares an Increase to the Quarterly Cash Dividend

    HOUSTON, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Powell Industries, Inc. (NASDAQ:POWL), a leading supplier of custom engineered solutions for the management, control and distribution of electrical energy, today announced that its Board of Directors has approved an increase to the quarterly cash dividend on the Company's common stock to $0.27 per share, equating to an annualized dividend of $1.08 per share from the current $1.07 per share. The dividend is payable on March 18, 2026, to shareholders of record at the close of business on February 18, 2026. Powell Industries, Inc., headquartered in Houston, Texas, develops, designs, manufactures and services custom-engineered equipment and systems t

    2/3/26 4:14:00 PM ET
    $POWL
    Electrical Products
    Energy

    MFS Announces Closed-End Fund Distributions

    MFS Investment Management® (MFS®) announced today monthly distributions of the following closed-end funds, all with declaration dates of February 2, 2026, ex-dividend dates of February 17, 2026, record dates of February 17, 2026, and payable dates of February 27, 2026: Fund (ticker) Income/Share Other Sources/Share* Total Amount/Share MFS® Charter Income Trust (NYSE:MCR)^ $0.0000 $0.044950 $0.044950 MFS® Government Markets Income Trust (NYSE:MGF)^ $0.0000 $0.019060 $0.019060 MFS® High Income Municipal Trust (NYSE:CXE) $0.0180 $0.0000 $0.0180 MFS® High Yield Municipal Trust

    2/2/26 4:15:00 PM ET
    $CIF
    $CMU
    $CXE
    Trusts Except Educational Religious and Charitable
    Finance
    Investment Managers
    Finance Companies

    $ACLX
    $AGTC
    $ALPP
    $BBN
    Leadership Updates

    Live Leadership Updates

    View All

    Quantum Appoints William H. White as Chief Financial Officer

    Seasoned finance executive brings growth-focused mindset to advancing Quantum's long-term strategy Quantum Corporation (NASDAQ:QMCO) today announced the appointment of William H. White as its Chief Financial Officer. White will lead Quantum's global finance organization, including financial strategy and operations, capital structure initiatives, and investor relations, supporting the company's next phase of growth and operational execution. White brings more than two decades of experience transforming technology companies through disciplined financial leadership and strategic capital allocation. He is recognized for improving operational rigor and modernizing reporting and forecasting p

    2/2/26 8:00:00 AM ET
    $QMCO
    Electronic Components
    Technology

    ORIC® Pharmaceuticals Provides Operational Highlights for 2025 and Anticipated Upcoming Milestones

    Announced rinzimetostat (ORIC-944) Phase 1b data that continue to demonstrate potential best-in-class efficacy and safety in mCRPC; selected provisional RP2Ds and initiated dose optimization in combination with AR inhibitors Presented potential best-in-class enozertinib Phase 1b data demonstrating highly competitive systemic and intracranial activity in NSCLC patients with EGFR exon 20 and EGFR PACC mutations; selected Phase 3 monotherapy dose Raised $244 million from top-tier healthcare specialist funds; Cash and investments of $413 million expected to provide runway into 2H 2028 and beyond anticipated primary endpoint readout for rinzimetostat Phase 3 study Expect to report multiple cli

    1/12/26 8:30:00 AM ET
    $ORIC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    ORIC® Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Clinical and Operational Updates

    Announced completion of dose exploration portion of ORIC-944 Phase 1b clinical trial and presented data that continues to demonstrate potential best-in-class efficacy and safety Bolstered leadership team with the appointment of Kevin Brodbeck, PhD, as Chief Technical Officer to further support ORIC's transition to potential late-stage development Cash and investments of approximately $413 million expected to provide runway into 2H 2028 and beyond anticipated primary endpoint readouts from first Phase 3 trials for ORIC-944 and enozertinib (ORIC-114) Expects to report four clinical data readouts across ORIC-944 and enozertinib (ORIC-114) programs through mid-2026, ahead of potential initiat

    11/13/25 4:10:00 PM ET
    $ORIC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACLX
    $AGTC
    $ALPP
    $BBN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Federated Hermes Premier Municipal Income Fund

    SC 13D/A - Federated Hermes Premier Municipal Income Fund (0001199004) (Subject)

    12/13/24 5:01:17 PM ET
    $FMN
    Investment Managers
    Finance

    Amendment: SEC Form SC 13D/A filed by Pioneer Municipal High Income Advantage Fund Inc.

    SC 13D/A - PIONEER MUNICIPAL HIGH INCOME ADVANTAGE FUND, INC. (0001258943) (Subject)

    12/13/24 4:29:08 PM ET
    $MAV
    Finance Companies
    Finance

    Amendment: SEC Form SC 13D/A filed by Blackrock MuniHoldings New York Quality Fund Inc.

    SC 13D/A - BLACKROCK MUNIHOLDINGS NEW YORK QUALITY FUND, INC. (0001038186) (Subject)

    12/13/24 4:14:12 PM ET
    $MHN
    Investment Bankers/Brokers/Service
    Finance